InvestorsHub Logo
Followers 698
Posts 59465
Boards Moderated 18
Alias Born 06/01/2008

Re: None

Friday, 01/19/2018 2:14:16 PM

Friday, January 19, 2018 2:14:16 PM

Post# of 650
Maricann Announces Operational Update

BY Marketwire - Canada
— 11:35 AM ET 01/11/2018

BURLINGTON, ONTARIO--(Marketwired - Jan. 11, 2018) - Maricann Group Inc. ( MRRCF ) (CSE:MARI.CN)("Maricann" or "The Company"), is pleased to provide investors with the following Operational Update post the closing of our recent $40MM financing.

Canadian Operations

-- Phase One construction of our state-of-the-art Langton, ON facility is currently on time and within 2% of budget. We anticipate planting to
begin in Q2 of 2018 following a Health Canada Inspection. Initial
production capacity is expected to be 22,500 kg per year.
-- The main processing area is structurally complete (90,000 sq. ft)
-- The mother, clone, and vegetation area is structurally complete (37,000sq. ft)
-- The 1.55MM litre water cistern is structurally complete

Please see link for an overhead illustration of the facility - http://bit.ly/2CPCFsZ


-- Phase Two and Phase Three construction has commenced, targeted to bring
our future capacity to 95,000 kg per year.
-- The Pilot of our retail pharmacy partnership with a leading Canadian
pharmacy operator kicks off this month. National Launch is expected to move forward in April 2018. This exclusive agreement will allow Maricann to supply patients of approx. 25% of Canada's pharmacies directly with
medicinal cannabis

German Operations - Q1

-- We anticipate to receive both a Narcotics Import and Wholesale license
by the end of March 2018
-- We expect to receive GMP certification of our Canadian operations,
permitting export to Germany of packaged dry cannabis flowers in
February 2018.
-- We expect to start distributing 25mg CBD VesiSorb capsules in February
2018.